血清壳多糖酶3样蛋白1水平与肝脏弹性值测定对肝纤维化诊断价值的比较

doi:10.3969/j.issn.1671-7171.2021.06.002

Abstract
Figure/Table
References
Related Citation (11)

Download: PDF (1182 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the diagnostic value of the serum chitinase 3-like protein 1 (CHI3L1) level and Fibroscan in patients with liver fibrosis. 【Methods】A total of 392 outpatients and inpatients in the Department of Liver Diseases of Hunan Provincial People's Hospital from September 2018 to December 2019 were collected. Fibroscan was used to measure liver elasticity (LS). LS value ≤7.3 kPa was included in the non-fibrosis group (n=115), LS value ≤17.4 kPa was included in the fibrosis group (n=85), and LS value ≥17.5 kPa was included in the cirrhosis group group (n=192).Enzyme-linked immunosorbent assay (ELISA) was used to detect serum CHI3L1 levels in all subjects, an automatic biochemical analyzer was used to determine patient liver function indexes (ALT, AST, TBIL, DBIL, TP, ALB), and Fibroscan was used to determine liver stiffness (LS). The correlation between CHI3L1 and liver function indexes was analyzed and the ROC curve of serum CHI3L1 level and LS value in the diagnosis of liver fibrosis patients was drawn.【Results】The clinical data of the three groups of patients were compared, and the difference of age, BMI, combined drinking history were statistically significant (P<0.05). The CHI3L1, LS, liver function indexes (ALT, AST, TBIL, DBIL, TP, ALB) of each group were compared, and the differences were statistically significant (P<0.05). The level of CHI3L1 in the non-fibrosis group was not correlated with various liver function indexes and LS values (P>0.05). The level of serum CHI3L1 in the fibrosis group was not correlated with various liver function indexes (P>0.05), but positively correlated with LS (P<0.05). Serum CHI3L1 level in the cirrhosis group was positively correlated with ALT and LS, negatively correlated with ALB (P<0.05), and not correlated with AST, TBIL, DBIL, TP (P>0.05). The area under curve of the serum CHI3L1 and LS value are 0.841 and 0.717, respectively. Both methods have high diagnostic efficiency for patients with liver fibrosis, and the diagnostic efficiency of serum CHI3L1 is slightly higher than the LS value. 【Conclusion】Serum CHI3L1 levels are closely related to liver function indexes such as ALT and ALB, and can reflect early liver damage. Compared with Fibroscan, it has higher diagnostic efficiency in patients with liver fibrosis and is worthy of clinical promotion.

Key words： Liver Cirrhosis/DI Elasticity Imaging Techniques Chitinase-3-Like Protein 1/BL

Received: 22 January 2021

PACS:

R657.31

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MAO Zhuo
	LIAO Ai-jun
	LIAO Jin-mao
	et al

Cite this article:

MAO Zhuo,LIAO Ai-jun,LIAO Jin-mao, et al. Comparison of the Diagnostic Value of Serum Chitinase 3-like Protein 1 Level and Liver Elasticity in the Diagnosis of Liver Fibrosis[J]. JOURNAL OF CLINICAL RESEARCH, 2021, 38(6): 806-810.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2021.06.002 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2021/V38/I6/806

[1] 夏海珊,陈少茹,钟月春,等.肝纤维化的发病机制和药物治疗现况[J].中国医药导报,2014,11(18):162-165.
[2] 曹建彪,陈永平,成军,等.瞬时弹性成像技术(TE)临床应用专家共识(2015年)[J].中国肝脏病杂志(电子版),2015,7(2):12-18.
[3] LEE Y R, PARK S Y, KIM S U, et al.Prediction of hepatocellular carcinoma recurrence after radiofrequency ablation using liver stiffness measurement (fibroscan)[J].J Hepatol,2016, 64(2):S741.
[4] LOMBARDI R, PETTA S, GIANNETTI A, et al.Fibroscan liver stiffness (LMS) and controlled attenuation parameter (CAP) in the evaluation of cardiovascular risk assessment in patients with NAFLD[J].Dig Liver Dis,2018, 50(1):37.
[5] XIN JIN, BIN FU, ZHENG-JIE WU,et al.Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China[J].Hepatobiliary Pancreat Dis Int,2020, 19(4):384-389.
[6] ZHAO T, SU Z, LI Y, et al.Chitinase-3 like-protein-1 function and its role in diseases[J].Signal Transduct Target Ther,2020, 5(1):201.
[7] 陆伦根,尤红,谢渭芬,等.肝纤维化诊断及治疗共识(2019年)[J].临床肝胆病杂志,2019,35(10):2163-2172.
[8] 王民,罗文萍,张冠华,等.FibroTouch、FibroScan及ARFI在原发性胆汁性胆管炎相关肝纤维化中的诊断价值[J].临床肝胆病杂志,2021,37(4):817-822.
[9] 范慧宁,陈尼维.肝纤维化的流行病学研究进展[J].国际消化病杂志,2014,34(1):29-31.
[10] MASTMEYER A, FORTMEIER D, HANDELS H.Evaluation of direct haptic 4d volume rendering of partially segmented data for liver puncture simulation[J].Sci Rep,2017, 7(1):671.
[11] MAKLED M N, EL-AWADY M S, ABDELAZIZ R R, et al.Pomegranate protects liver against cecal ligation and puncture-induced oxidative stress and inflammation in rats through TLR4/NF-κB pathway inhibition[J].Environ Toxicol Pharmacol,2016, 43(4):182-192.
[12] FRIEDRICH-RUST M, ROMEN D, VERMEHREN J, et al.Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD[J].Eur J Radiol,2012, 81(3):e325-e331.
[13] 董阳,戴美云,马亚文,等.联合检测AFP、FER、CHI3L1和GP73在原发性肝癌诊断中的应用价值[J].国际消化病杂志,2018,38(06):393-396.
[14] BONDER A, AFDHAL N.Utilization of FibroScan in clinical practice[J].Curr Gastroenterol Rep,2014, 16(2):372.
[15] 李晓文,王后红,黄海,等.CHI3L1通过激活TGF-β信号通路促进肝细胞肝癌进展及分子机制[J].中国现代医生,2019,57(34):31-34.
[16] 王姗.血清GGT和AST/ALT对原发性肝癌预后的评估价值[J].临床肝胆病杂志,2019,35(10):2334.
[17] 陈成伟,成军,窦晓光,等.胆汁淤积性肝病诊断和治疗共识(2015)[J].临床肝胆病杂志,2015,31(12):1989-1999.
[18] 孟镇锴,李晓旭,瞿文生,等.Hepa RG和Hep G2细胞聚球体的生长形态、细胞色素P450酶和白蛋白表达及对药物肝毒性敏感性的比较[J].中国药理学与毒理学杂志,2019,33(1):44-53.
[19] 李晓霞,李彬,李林,等.肝纤维化血清标志物的临床应用评价[J].中国现代医生,2012,50(25):75-76.